In pulmonary embolism, fibrinolytic therapy is responsible for -
Risk of haemorrhage
Prognosis good
Massive emboli
All of the above
Hemorrhage is the main complication of fibrinolytic therapy, so it is contraindicated in all situations where the risk of bleeding is increased - recent trauma, surgery, biopsies, stroke, peptic ulcer, aneurysms, bleeding disorders, diabetes, acute pancreatitis etc.)